Mixed-type inhibition of pulmonary angiotensin I-converting enzyme by captopril, enalaprilat and ramiprilat (Q28610111)

3 February 2017

title

Mixed-type inhibition of pulmonary angiotensin I-converting enzyme by captopril, enalaprilat and ramiprilat (English)

1 reference

3 February 2017

B. Baudin

1

1 reference

3 February 2017

B. Bénéteau-Burnat

series ordinal

2

1 reference

3 February 2017

publication date

1 January 1999

1 reference

Journal of Enzyme Inhibition and Medicinal Chemistry

3 February 2017

published in

1 reference

3 February 2017

volume

14

1 reference

3 February 2017

issue

6

1 reference

3 February 2017

page(s)

447–456

1 reference

A continuous spectrophotometric assay for angiotensin converting enzyme

3 February 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F14756369909030335

Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369909030335

Angiotensin converting enzyme: substrate inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369909030335

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369909030335

Critical lysine residue at the chloride binding site of angiotensin converting enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369909030335

Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369909030335

10.3109/14756369909030335

21 January 2018

Identifiers

DOI

0 references

1 reference